Rasagiline Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-25-R-0020
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Defense Logistics Agency (DLA) Troop Support has issued a solicitation (Procurement Identifier: SPE2D2-25-R-0020) for the supply of Rasagiline Tablets, as detailed in the attached solicitation document. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating a focus on pharmaceuticals and drugs.
The primary objective of this solicitation is to secure a reliable source for Rasagiline Tablets, a pharmaceutical product commonly used in the treatment of Parkinson’s disease. The scope of the procurement encompasses the manufacturing and timely delivery of these tablets in accordance with the specifications and requirements outlined in the solicitation. The intended outcome is to ensure the continuous and uninterrupted supply of this critical medication to meet the needs of DLA Troop Support’s end users.
Key requirements for this opportunity include compliance with all applicable federal regulations governing pharmaceutical manufacturing, quality assurance, and delivery standards. Offerors are expected to demonstrate their capability to produce and supply Rasagiline Tablets that meet the required quality and safety standards. The solicitation may also specify packaging, labeling, and delivery requirements, as well as any necessary certifications or approvals, though interested parties should refer to the attached solicitation for complete details.
The contracting entity for this procurement is DLA Troop Support, a federal office responsible for providing logistical support to military and other government agencies. The primary point of contact for this solicitation is Kyle Lewicki, who can be reached at [email protected] or by phone at 445-737-0977. A secondary contact is Catherine Gilbert, available at [email protected] or 445-737-8868.
This is an active solicitation, with a posting date of April 9, 2025, and a response deadline of June 10, 2025, at 19:10. Interested contractors are encouraged to review the full solicitation document, which is available via the provided SAM.gov link (https://sam.gov/opp/0fea2a329f844c848072c9a0f24cfc4f/view), to ensure a comprehensive understanding of all requirements and submission instructions.
No specific set-aside requirements or special considerations are indicated in the provided information. Contractors with experience in pharmaceutical preparation manufacturing, particularly those capable of meeting federal supply standards for Rasagiline Tablets, are well-positioned to consider this opportunity. All interested parties should ensure their proposals address the constant elements of quality, regulatory compliance, and reliable delivery that will be expected throughout the contract lifecycle.